These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21151480)

  • 1. NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis.
    Yang C; McCoy K; Davis JL; Schmidt-Supprian M; Sasaki Y; Faccio R; Novack DV
    PLoS One; 2010 Nov; 5(11):e15383. PubMed ID: 21151480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms.
    Zeng R; Faccio R; Novack DV
    J Bone Miner Res; 2015 Dec; 30(12):2287-99. PubMed ID: 26094846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.
    Vaira S; Johnson T; Hirbe AC; Alhawagri M; Anwisye I; Sammut B; O'Neal J; Zou W; Weilbaecher KN; Faccio R; Novack DV
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3897-902. PubMed ID: 18322009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.
    Yao Z; Lei W; Duan R; Li Y; Luo L; Boyce BF
    J Biol Chem; 2017 Jun; 292(24):10169-10179. PubMed ID: 28438834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
    Yoon WJ; Kim KN; Heo SJ; Han SC; Kim J; Ko YJ; Kang HK; Yoo ES
    Biochem Biophys Res Commun; 2013 May; 434(4):892-7. PubMed ID: 23611776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional Activation of NF-κB Inducing Kinase (NIK) in the Osteolineage Enhances Both Basal and Loading-Induced Bone Formation.
    Davis JL; Cox L; Shao C; Lyu C; Liu S; Aurora R; Veis DJ
    J Bone Miner Res; 2019 Nov; 34(11):2087-2100. PubMed ID: 31246323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO.
    Adapala NS; Swarnkar G; Arra M; Shen J; Mbalaviele G; Ke K; Abu-Amer Y
    Elife; 2020 Mar; 9():. PubMed ID: 32202502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation.
    Xiu Y; Xu H; Zhao C; Li J; Morita Y; Yao Z; Xing L; Boyce BF
    J Clin Invest; 2014 Jan; 124(1):297-310. PubMed ID: 24316970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
    Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
    Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plumbagin is a NF-κB-inducing kinase inhibitor with dual anabolic and antiresorptive effects that prevents menopausal-related osteoporosis in mice.
    Shen G; Liu X; Lei W; Duan R; Yao Z
    J Biol Chem; 2022 Apr; 298(4):101767. PubMed ID: 35235833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
    Bharti AC; Takada Y; Aggarwal BB
    J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.
    Wang F; Zhang C; Ge W; Zhang G
    J Cell Mol Med; 2019 Oct; 23(10):6744-6754. PubMed ID: 31402549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
    Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y
    J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis.
    Novack DV; Yin L; Hagen-Stapleton A; Schreiber RD; Goeddel DV; Ross FP; Teitelbaum SL
    J Exp Med; 2003 Sep; 198(5):771-81. PubMed ID: 12939342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells.
    Shakibaei M; Buhrmann C; Mobasheri A
    J Biol Chem; 2011 Apr; 286(13):11492-505. PubMed ID: 21239502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G; Xu Q; Dai M; Liu X
    Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.